I'm liking this more and more - very focused on commercialisation. Good to see the BoD bringing in relevant expertise for the next stage.
Dr Kim provides services through several consultancies, but they're all involved in getting pharmaceuticals to market, licensing deals, partnering, etc.
https://www.spiegare.com.au/kim-agnew-2/
https://www.spiegare.com.au/services/
Moving forward...
- Forums
- ASX - By Stock
- NUZ
- Ann: Appendix 4C and Quarterly Update
Ann: Appendix 4C and Quarterly Update, page-20
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.015(8.11%) |
Mkt cap ! $98.34M |
Open | High | Low | Value | Volume |
19.0¢ | 20.0¢ | 19.0¢ | $66.44K | 346.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 86359 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 107894 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 86359 | 0.190 |
14 | 839962 | 0.185 |
8 | 336753 | 0.180 |
4 | 120797 | 0.175 |
5 | 159661 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 107894 | 5 |
0.205 | 109808 | 2 |
0.210 | 107676 | 2 |
0.215 | 154400 | 2 |
0.220 | 174409 | 3 |
Last trade - 15.42pm 13/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |